The United Laboratories International Holdings ( (HK:3933) ) has issued an announcement.
The United Laboratories International Holdings Limited has announced a proposed share buy-back under a general mandate, with plans to repurchase up to HK$200 million worth of ordinary shares in the open market. This initiative, financed by internal cash, aims to enhance the value of shares and improve shareholder returns, though its execution will depend on market conditions.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It is involved in the production and distribution of pharmaceutical products.
YTD Price Performance: 12.70%
Average Trading Volume: 9,827
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.32B
For a thorough assessment of 3933 stock, go to TipRanks’ Stock Analysis page.